MDT 10-Q Quarterly Report Jan. 28, 2022 | Alphaminr

MDT 10-Q Quarter ended Jan. 28, 2022

MEDTRONIC PLC
10-Ks and 10-Qs
10-Q
Quarter ended July 26, 2024
10-K
Fiscal year ended April 26, 2024
10-Q
Quarter ended Jan. 26, 2024
10-Q
Quarter ended Oct. 27, 2023
10-Q
Quarter ended July 28, 2023
10-K
Fiscal year ended April 28, 2023
10-Q
Quarter ended Jan. 27, 2023
10-Q
Quarter ended Oct. 28, 2022
10-Q
Quarter ended July 29, 2022
10-K
Fiscal year ended April 29, 2022
10-Q
Quarter ended Jan. 28, 2022
10-Q
Quarter ended Oct. 29, 2021
10-Q
Quarter ended July 30, 2021
10-K
Fiscal year ended April 30, 2021
10-Q
Quarter ended Jan. 29, 2021
10-Q
Quarter ended Oct. 30, 2020
10-Q
Quarter ended July 31, 2020
10-K
Fiscal year ended April 24, 2020
10-Q
Quarter ended Jan. 24, 2020
10-Q
Quarter ended Oct. 25, 2019
10-Q
Quarter ended July 26, 2019
10-K
Fiscal year ended April 26, 2019
10-Q
Quarter ended Jan. 25, 2019
10-Q
Quarter ended Oct. 26, 2018
10-Q
Quarter ended July 27, 2018
10-K
Fiscal year ended April 27, 2018
10-Q
Quarter ended Jan. 26, 2018
10-Q
Quarter ended Oct. 27, 2017
10-Q
Quarter ended July 28, 2017
10-K
Fiscal year ended April 28, 2017
10-Q
Quarter ended Jan. 27, 2017
10-Q
Quarter ended Oct. 28, 2016
10-Q
Quarter ended July 29, 2016
10-K
Fiscal year ended April 29, 2016
10-Q
Quarter ended Jan. 29, 2016
10-Q
Quarter ended Oct. 30, 2015
10-Q
Quarter ended July 31, 2015
10-K
Fiscal year ended April 24, 2015
10-Q
Quarter ended Jan. 23, 2015
PROXIES
DEF 14A
Filed on Aug. 9, 2024
DEF 14A
Filed on Aug. 11, 2023
DEF 14A
Filed on Aug. 19, 2022
DEF 14A
Filed on Aug. 27, 2021
DEF 14A
Filed on Aug. 14, 2020
DEF 14A
Filed on Aug. 16, 2019
DEF 14A
Filed on Aug. 24, 2018
DEF 14A
Filed on Aug. 28, 2017
DEF 14A
Filed on Aug. 10, 2016
DEF 14A
Filed on July 24, 2015
TABLE OF CONTENTS
Part I Financial InformationItem 1. Financial StatementsItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II Other InformationItem 1. Legal ProceedingsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 5. Other InformationItem 6. Exhibits

Exhibits

10.1 Medtronic Capital Accumulation Plan Deferral Program (as restated generally effective January 1, 2017) (Conformed through the Amendment generally effective as of January 1, 2022) 10.2 2021 Medtronic plc Long Term Incentive Plan 10.3 Performance Share Unit Agreement 2021 Medtronic plc Long Term Incentive Plan 10.4 Non-Qualified Stock Option Agreement 2021 Medtronic plc Long Term Incentive Plan 10.5 Restricted Stock Unit Award Agreement for awards vesting 100% on the third anniversary of the grant date - 2021 Medtronic plc Long Term Incentive Plan 10.6 Restricted Stock Unit Award Agreement for awards vesting ratably on the first, second, third, and fourth anniversary of the grant date - 2021 Medtronic plc Long Term Incentive Plan 31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1 Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2 Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.